Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial
-
Published:2024-02-01
Issue:3
Volume:57
Page:408-417
-
ISSN:1573-742X
-
Container-title:Journal of Thrombosis and Thrombolysis
-
language:en
-
Short-container-title:J Thromb Thrombolysis
Author:
Sim Hui WenORCID, Koh Karen W. L., Poh Sock-Cheng, Chan Siew Pang, Marchesseau Stephanie, Singh Devinder, Han Yiying, Ng Faclin, Lim Eleanor, Prabath Joseph F., Lee Chi-Hang, Chen Ruth, Carvalho Leonardo, Tan Sock-Hwee, Loh Joshua P. Y., Tan Jack W. C., Kuwelker Karishma, Amanullah R. M., Chin Chee-Tang, Yip James W. L., Lee Choy-Yee, Gan Juvena, Lo Chew-Yong, Ho Hee-Hwa, Hausenloy Derek J., Tai Bee-Choo, Richards A. Mark, Chan Mark Y.
Funder
National Medical Research Council AstraZeneca
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G et al (2017) Global, Regional, and National Burden of Cardiovascular Diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70(1):1–25 2. Bonaca MP, Braunwald E, Sabatine MS (2015) Long-term use of Ticagrelor in patients with prior Myocardial Infarction. N Engl J Med 373(13):1274–1275 3. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057 4. Van Giezen JJJ, Nilsson L, Berntsson P, Wissing B-M, Giordanetto F, Tomlinson W et al (2009) Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. J Thromb Haemost 7(9):1556–1565 5. Bae JP, Dobesh PP, Klepser DG, Anderson JD, Zagar AJ, McCollam PL et al (2012) Adherence and dosing frequency of common medications for cardiovascular patients. Am J Manag Care 18(3):139–146
|
|